SOMALOGIC OPERATING CO., INC.
BOULDER, CO

SomaLogic Operating Co., Inc. is an innovative biotechnology firm based in Boulder, Colorado, specializing in providing precision digital health insights through the measurement of proteins as biomarkers. SomaLogic is dedicated to collaborating with global partners to enhance healthcare providers' and consumers' understanding of health and disease management. Recently, the company announced that Melody Harris has joined its team as Chief Legal Officer, bringing valuable experience from Qualcomm Life where she served as Vice President and Chief Counsel. In a significant financial development, SomaLogic successfully completed a $200 million funding round led by iCarbonX and supported by substantial investment from Nan Fung Life Sciences and Madryn Asset Management. This milestone accelerates SomaLogic's ambition to become the leading provider of precision digital health insights worldwide. Under the leadership of Director Michael Egholm, who also serves as President, along with Jeffrey G Black, the company continues its mission of delivering actionable health insights derived from analyzing protein levels. Their expertise extends to identifying diseases, assessing lifestyle impacts on health, and predicting future health challenges. SomaLogic's core technology is centered around its unique ability to measure changes in proteins over time, offering personalized health information that empowers individuals to make informed decisions regarding their wellness. The company leverages a global ecosystem of partners to provide these valuable insights through advanced biomarker analyses. Founded by Russell T. Ray on December 8, 2015, SomaLogic was originally registered as SOMALOGIC, INC., based in DE, with its headquarters located at 2945 Wilderness Place in Boulder, CO, and is registered under Fei Number 52-2195896. The company remains an important player in the biotechnology sector through its focus on groundbreaking research and health solutions.